This story originally ran on April 29.
This week the National Cancer Institute issued a request for applications for exploratory research in human cancer proteomics as part of its participation in the Research and Research Infrastructure Grand Opportunities Program.
The so-called GO program is part of the American Recovery & Reinvestment Act of 2009, more commonly known as the economic stimulus bill, and awards up to $200 million "to support high impact ideas that lend themselves to short-term funding, and may lay the foundation for new fields of investigation," NCI said in an announcement.
The RFA announced this week provides up to $10 million for the development of large-scale research pilot projects "that will provide a foundation for pursuing the development of human cancer proteomes."
Applications must meet two of three requirements to get funded: developing or optimizing mass spectrometry or other protein/peptide detection technologies and necessary reagents that will allow researchers to quantitatively measure aberrant and normal human proteins in biological samples with state-of-the-art sensitivity and specificity; developing or optimizing image-analysis technologies along with necessary reagents to measure aberrant and normal human proteins in biological samples; and "promoting synergies between genomics-proteomics as related to defining clinical issues in cancer."
The application deadline is May 27, and the earliest anticipated start date is Sept. 30.
More information about the GO program and the application process is available here.